2018
DOI: 10.1007/s11696-018-0410-1
|View full text |Cite
|
Sign up to set email alerts
|

Environmental toxicity study of poly(2-oxazoline)s

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…PMetOx of different degrees of polymerization (DP) were prepared through living cationic ringopening polymerization of 2-methyl-2-oxazoline, initiated by methyl 4-nitrobenzenesulfonate (MeONs) according to a standard procedure. [40,41] The polymerizations were performed in ACN solution (4 mol L −1 ) at 80 C for 23 or 88 hr giving respectively DP of 50 or 200. The reactions were terminated by 0.1 M methanolic KOH (1.1 equivalents to MeONs).…”
Section: Synthesis Of Pmetox-co-pei Copolymersmentioning
confidence: 99%
“…PMetOx of different degrees of polymerization (DP) were prepared through living cationic ringopening polymerization of 2-methyl-2-oxazoline, initiated by methyl 4-nitrobenzenesulfonate (MeONs) according to a standard procedure. [40,41] The polymerizations were performed in ACN solution (4 mol L −1 ) at 80 C for 23 or 88 hr giving respectively DP of 50 or 200. The reactions were terminated by 0.1 M methanolic KOH (1.1 equivalents to MeONs).…”
Section: Synthesis Of Pmetox-co-pei Copolymersmentioning
confidence: 99%
“…With folic acid as a model drug mixed into TEA (PCL-b-PVP) 3 micelles, the drug loading and encapsulation efficiency were 16.36% and 49.08%, respectively [167]. POx is also called "pseudopeptides" as a result of its structure similar to poly (amino acid) [168]. Similarly, it has become another substitute for PEG, due to its biocompatibility, high degree of solubility adjustment, size change, structure and chemical function.…”
Section: Synthetic Polymermentioning
confidence: 99%
“…An inherent problem of carrier nanomedicine is that its drug-carrying capacity is still low (usually <10 wt%), which hinders the accumulation of effective drugs and the therapeutic effects of drugs. The drug inertness of the nanocarrier and the excessive chemical treatment during the preparation process will bring potential harm to the body [167,168]. In order to avoid these hazards, carrier-free nanomedicines, whose nanomaterial matrix is mainly composed of active pharmaceutical ingredients, were developed.…”
Section: Carrier-free Nanomedicines Delivery Systemmentioning
confidence: 99%
“…as the polymeric fertilizer, with the potential to slowly release nitrogen that can be metabolized by plants. As an example, De Varennes et al examined the stimulation effect of polyacrylates neutralized with NH 4 + ions on ryegrass growth and development [32] and, recently, Hrdlička et al demonstrated a different sphytotoxicological effect of selected poly(2-oxazoline)s on the growth of Sinapis alba [33].…”
Section: Introductionmentioning
confidence: 99%